Skip to main content
Erschienen in: Neuroradiology 8/2004

01.08.2004 | Diagnostic Neuroradiology

Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings

verfasst von: I. Chan Chiang, Yu-Ting Kuo, Chia-Ying Lu, Kwok-Wan Yeung, Wei-Chen Lin, Feng-O. Sheu, Gin-Chung Liu

Erschienen in: Neuroradiology | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

This study compared the effectiveness of relative cerebral blood volume, apparent diffusion coefficient, and spectroscopic imaging in differentiating between primary high-grade gliomas and solitary metastases. A 3.0-T MR unit was used to perform proton MR spectroscopy, diffusion imaging, and conventional MR imaging on 26 patients who had solitary brain tumors (14 high-grade gliomas and 12 metastases). All diagnoses were confirmed by biopsy. Twelve perfusion MR studies (8 high-grade gliomas and 4 metastases) were also performed. The results showed that the choline to creatine ratio and relative cerebral blood volume in the peritumoral regions of high-grade gliomas were significantly higher than they were in the metastases. The apparent diffusion coefficient values in tumoral and peritumoral regions of metastases were significantly higher than they were in the primary gliomas. Although conventional MR imaging characteristics of solitary metastases and primary high-grade gliomas may sometimes be similar, the peritumoral perfusion-weighted and spectroscopic MR imaging enable distinction between the two. Diffusion-weighted imaging techniques were complementary techniques to make a differential diagnosis between the two malignant tumors.
Literatur
1.
Zurück zum Zitat Kaminogo M, Ishimaru H, Morikawa M et al. (2001) Diagostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 43:353–363CrossRefPubMed Kaminogo M, Ishimaru H, Morikawa M et al. (2001) Diagostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 43:353–363CrossRefPubMed
2.
Zurück zum Zitat Luyten PR, Marien AJ, Heindel W et al. (1990) Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791–799PubMed Luyten PR, Marien AJ, Heindel W et al. (1990) Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791–799PubMed
3.
Zurück zum Zitat Alger JR, Frank JA, Bizzi A et al. (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633–641PubMed Alger JR, Frank JA, Bizzi A et al. (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633–641PubMed
4.
Zurück zum Zitat Nelson SJ, Huhn S, Vigneron DB et al. (1997) Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors. Magn Reson Imaging 7:1146–1152 Nelson SJ, Huhn S, Vigneron DB et al. (1997) Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors. Magn Reson Imaging 7:1146–1152
5.
Zurück zum Zitat Vigneron DB, Bollen A, McDermott M et al. (2001) Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 19:89–101CrossRefPubMed Vigneron DB, Bollen A, McDermott M et al. (2001) Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 19:89–101CrossRefPubMed
6.
Zurück zum Zitat Krabbe K, Gideon P, Wagn P, Hansen U, Thosem C, Madsen F (1997) MR diffusion imagng of human intracranial tumors. Diagn Neuroradiol 39:483–489CrossRef Krabbe K, Gideon P, Wagn P, Hansen U, Thosem C, Madsen F (1997) MR diffusion imagng of human intracranial tumors. Diagn Neuroradiol 39:483–489CrossRef
7.
Zurück zum Zitat Roland G, Daniel B, Vigneron N et al. (2001) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366 Roland G, Daniel B, Vigneron N et al. (2001) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366
8.
Zurück zum Zitat Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial neoplasms. J Neurosurg 66:865–874PubMed Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial neoplasms. J Neurosurg 66:865–874PubMed
9.
Zurück zum Zitat Henry RG, Vigneron DB, Fischbein NJ et al. (2000) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366PubMed Henry RG, Vigneron DB, Fischbein NJ et al. (2000) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366PubMed
10.
Zurück zum Zitat Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am8:733–752 Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am8:733–752
11.
Zurück zum Zitat McBride DQ, Miller BL, Nikas DL et al. (1995) Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 44:137–144CrossRefPubMed McBride DQ, Miller BL, Nikas DL et al. (1995) Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 44:137–144CrossRefPubMed
12.
Zurück zum Zitat Shimuzu H, Kumabe T, Tominaga T et al. (1996) Non-invasive evaluation of malignat brain tumors wityh proton MR spectroscopy. AJNR Am J Neuroradiol 17:737–747PubMed Shimuzu H, Kumabe T, Tominaga T et al. (1996) Non-invasive evaluation of malignat brain tumors wityh proton MR spectroscopy. AJNR Am J Neuroradiol 17:737–747PubMed
13.
Zurück zum Zitat Knopp EA, Cha S, Johnson G et al. (1999) Glial neoplasms: dynamic contrast enhanced T2-weighted MR imaging. Radiology 211:791–798PubMed Knopp EA, Cha S, Johnson G et al. (1999) Glial neoplasms: dynamic contrast enhanced T2-weighted MR imaging. Radiology 211:791–798PubMed
14.
Zurück zum Zitat Tien RD, Felsberg GJ, Friedman H, Brown M, McFall J (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162:671–677PubMed Tien RD, Felsberg GJ, Friedman H, Brown M, McFall J (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162:671–677PubMed
15.
Zurück zum Zitat Brunberg JA, Chenevert TL, MckeeverPE et al. (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of cerebral hemispheres. AJNR Am J Neuroradiol 16:361–371PubMed Brunberg JA, Chenevert TL, MckeeverPE et al. (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of cerebral hemispheres. AJNR Am J Neuroradiol 16:361–371PubMed
16.
Zurück zum Zitat Lu S, Ahn D, Johnson G, Cha S (2003) Peritumoral diffusion tensor imaging of high- grade gliomas and metastatic brain tumos. AJNR Am J Neuroradiol 24:937–941PubMed Lu S, Ahn D, Johnson G, Cha S (2003) Peritumoral diffusion tensor imaging of high- grade gliomas and metastatic brain tumos. AJNR Am J Neuroradiol 24:937–941PubMed
17.
Zurück zum Zitat Steen RG (1992) Edema and tumor perfusion: characterization by quantitative proton MR imaging. AJR Am J Roentgenol 158:259–264PubMed Steen RG (1992) Edema and tumor perfusion: characterization by quantitative proton MR imaging. AJR Am J Roentgenol 158:259–264PubMed
18.
Zurück zum Zitat Zhang M, Olsson Y (1997) Hematogenous metastases of the human brain: characteristics of peritumoral brain changes—a review. J Neurooncol 35:81–89CrossRefPubMed Zhang M, Olsson Y (1997) Hematogenous metastases of the human brain: characteristics of peritumoral brain changes—a review. J Neurooncol 35:81–89CrossRefPubMed
19.
Zurück zum Zitat Hossman KA, Bloink M (1981) Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 12:211–217PubMed Hossman KA, Bloink M (1981) Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 12:211–217PubMed
20.
Zurück zum Zitat Burger P (1990) Classification, grading, and patterns of spread of malignant gliomas. In: Apuzzo ML (eds) Neurosurgical topics: malignant cerebral glioma. American Association of Neurological Surgeons, Park Ridge, 3–17 Burger P (1990) Classification, grading, and patterns of spread of malignant gliomas. In: Apuzzo ML (eds) Neurosurgical topics: malignant cerebral glioma. American Association of Neurological Surgeons, Park Ridge, 3–17
21.
Zurück zum Zitat Aronen HJ, Gazit IE, Louis DN et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMed Aronen HJ, Gazit IE, Louis DN et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMed
22.
Zurück zum Zitat Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 16:1593–1603PubMed Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 16:1593–1603PubMed
23.
Zurück zum Zitat Bruhn H, Frahm J, Gyngell ML et al. (1989) Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172:541–548PubMed Bruhn H, Frahm J, Gyngell ML et al. (1989) Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172:541–548PubMed
24.
Zurück zum Zitat Preul MC, Caramanos Z, Collins DL et al. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323–325PubMed Preul MC, Caramanos Z, Collins DL et al. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323–325PubMed
25.
Zurück zum Zitat Sugahara T, Korogi Y, Kochi M et al. (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486PubMed Sugahara T, Korogi Y, Kochi M et al. (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486PubMed
26.
Zurück zum Zitat Li X, Lu y, Pirzkall A, McKnight T, Nelson S (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229–237CrossRefPubMed Li X, Lu y, Pirzkall A, McKnight T, Nelson S (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229–237CrossRefPubMed
27.
Zurück zum Zitat Ikehira H, Miyamoto T, Yasukawa T et al. (1995) Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Radiat Med 13:199–204PubMed Ikehira H, Miyamoto T, Yasukawa T et al. (1995) Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Radiat Med 13:199–204PubMed
28.
Zurück zum Zitat Usenius T, Usenius J, Tenhunen M et al. (1995) Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 33:719–724CrossRefPubMed Usenius T, Usenius J, Tenhunen M et al. (1995) Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 33:719–724CrossRefPubMed
29.
Zurück zum Zitat Walecki J, Sokol M, Pieniazek P et al. (1999) Role of short TE 1H-MR spectroscopy in monitoring of postoperation irradiated patients. Eur J Radiol 30:154–161CrossRefPubMed Walecki J, Sokol M, Pieniazek P et al. (1999) Role of short TE 1H-MR spectroscopy in monitoring of postoperation irradiated patients. Eur J Radiol 30:154–161CrossRefPubMed
30.
Zurück zum Zitat Taylor JS, Langston JW, Reddick WE et al. (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261CrossRefPubMed Taylor JS, Langston JW, Reddick WE et al. (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261CrossRefPubMed
31.
Zurück zum Zitat Ricci PE, Pitt A, Keller PJ, Coons SW, Heiserman JE (2000) Effect of voxel position on single-voxel MR spectroscopy findings. AJR Am J Neuroradiol 21:367–337 Ricci PE, Pitt A, Keller PJ, Coons SW, Heiserman JE (2000) Effect of voxel position on single-voxel MR spectroscopy findings. AJR Am J Neuroradiol 21:367–337
32.
Zurück zum Zitat Meng L, Soonmee C, Knopp EA, Johnson G, Arnett BS, Litt AW (2002) High grade-gliomas and solitary metasases: differentiaition by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721PubMed Meng L, Soonmee C, Knopp EA, Johnson G, Arnett BS, Litt AW (2002) High grade-gliomas and solitary metasases: differentiaition by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721PubMed
Metadaten
Titel
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings
verfasst von
I. Chan Chiang
Yu-Ting Kuo
Chia-Ying Lu
Kwok-Wan Yeung
Wei-Chen Lin
Feng-O. Sheu
Gin-Chung Liu
Publikationsdatum
01.08.2004
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 8/2004
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1246-7

Weitere Artikel der Ausgabe 8/2004

Neuroradiology 8/2004 Zur Ausgabe

Announcements

August 2004

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.